Catalent

Activity by year

20192020202120222023202420252026

ExpansionAcquisitionContract

Apr 25, 2022CONTRACTUnited States
ERYTECH and Catalent enter long-term supply agreement for eryaspase
ERYTECH and Catalent have entered a long-term supply agreement for the clinical and commercial supply of eryaspase (GRASPA).
ERYTECH Pharma Catalent supplier #Medical Devices stocktitan.net
Apr 25, 2022ACQUISITIONUnited States (facility location not specified further), United States$44.5M
Catalent acquires ERYTECH's U.S. manufacturing facility for $44.5M
Catalent has acquired ERYTECH's U.S. cell therapy manufacturing facility for $44.5 million. The companies also entered a long-term supply agreement for eryaspase (GRASPA).
Catalent acquirer ERYTECH Pharma target #Medical Devices stocktitan.net
Jan 7, 2019EXPANSIONBloomington, Indiana, United States$100.0M200 jobsops Apr 2019
Catalent expands biologics manufacturing operations in Bloomington, Indiana
Catalent commenced a significant expansion of its biologics manufacturing operations in Bloomington, Indiana, with plans to create up to 200 new jobs by 2024 and invest over $100 million, including $14 million for packaging expansion.
Catalent #Medical Devices iedc.in.gov

Site	Largest	Latest
Bloomington, United States	$100.0M	2019-01-07

Acquired

Loading…